Hirtle Callaghan & Co’s Abbott ABT Stock Holding History

Hirtle Callaghan & Co’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,551	Closed	-$289K	–	108
2024 Q4	$289K	Buy	+2,551	New	+$295K	0.01%	103
2022 Q3	–	Sell	-15,866	Closed	-$1.72M	–	103
2022 Q2	$1.72M	Sell	15,866 -4,659	-23%	-$529K	0.1%	51
2022 Q1	$2.43M	Buy	20,525 +16,247	+380%	+$2.01M	0.12%	42
2021 Q4	$602K	Buy	+4,278	New	+$548K	0.03%	61
2019 Q1	–	Sell	-645	Closed	-$47K	–	74
2018 Q4	$47K	Buy	+645	New	+$45.3K	﹤0.01%	100
2016 Q1	–	Sell	-5,176	Closed	-$232K	–	171
2015 Q4	$232K	Hold	5,176	–	–	0.05%	44
2015 Q3	$208K	Hold	5,176	–	–	0.04%	73
2015 Q2	$254K	Buy	+5,176	New	+$249K	0.09%	58
2015 Q1	–	Sell	-23,419	Closed	-$1.05M	–	17
2014 Q4	$1.05M	Sell	23,419 -100	-0.4%	-$4.36K	0.24%	62
2014 Q3	$978K	Sell	23,519 -340	-1%	-$14.4K	0.16%	68
2014 Q2	$976K	Hold	23,859	–	–	0.14%	96
2014 Q1	$919K	Sell	23,859 -350	-1%	-$13.5K	0.15%	86
2013 Q4	$928K	Buy	24,209 +601	+3%	+$22.2K	0.12%	89
2013 Q3	$784K	Buy	23,608 +20,326	+619%	+$713K	0.13%	96
2013 Q2	$114K	Buy	+3,282	New	+$120K	1.32%	22

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Hirtle Callaghan & Co's ABT Position: Q1 2025 in Review

Hirtle Callaghan & Co sold out of Abbott (ABT) in Q1 2025, closing a stake of 2,551 shares — an estimated $289K sold.

Hirtle Callaghan & Co first reported a position in ABT in Q2 2013 and held it in 15 quarters. The position peaked at $2.43M in Q1 2022. 3,168 funds tracked by Wall St. Rank hold ABT as of Q1 2025.

Hirtle Callaghan & Co reported no remaining Abbott position as of Q1 2025 after selling out during the quarter.
Hirtle Callaghan & Co sold 2,551 Abbott shares in Q1 2025, an estimated $289K.
Hirtle Callaghan & Co first reported a position in Abbott in Q2 2013 and held it in 15 quarters.
Hirtle Callaghan & Co's Abbott position peaked at $2.43M in Q1 2022.
3,168 funds tracked by Wall St. Rank held Abbott as of Q1 2025.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2025, filed 12 May 2025.